{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:54:45Z","timestamp":1787018085098,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:p>\n                    Evidence from human and animal studies has documented elevated levels of lysosomal cysteine protease cathepsin K in failing hearts. Here, we hypothesized that ablation of cathepsin K mitigates pressure overload\u2013induced cardiac hypertrophy. Cathepsin K knockout mice and their wild-type littermates were subjected to abdominal aortic constriction, resulting in cardiac remodeling (heart weight, cardiomyocyte size, left ventricular wall thickness, and end diastolic and end systolic dimensions) and decreased fractional shortening, the effects of which were significantly attenuated or ablated by cathepsin K knockout. Pressure overload dampened cardiomyocyte contractile function along with decreased resting Ca\n                    <jats:sup>2+<\/jats:sup>\n                    levels and delayed Ca\n                    <jats:sup>2+<\/jats:sup>\n                    clearance, which were partly resolved by cathepsin K knockout. Cardiac mammalian target of rapamycin and extracellular signal-regulated kinases (ERK) signaling cascades were upregulated by pressure overload, the effects of which were attenuated by cathepsin K knockout. In cultured H9c2 myoblast cells, silencing of cathepsin K blunted, whereas cathepsin K transfection mimicked phenylephrine\u2013induced hypertrophic response, along with elevated phosphorylation of mammalian target of rapamycin and ERK. In addition, cathepsin K protein levels were markedly elevated in human hearts of end-stage dilated cardiomyopathy. Collectively, our data suggest that cathepsin K ablation mitigates pressure overload\u2013induced hypertrophy, possibly via inhibition of the mammalian target of rapamycin and ERK pathways.\n                  <\/jats:p>","DOI":"10.1161\/hypertensionaha.111.00947","type":"journal-article","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T21:23:28Z","timestamp":1364246608000},"page":"1184-1192","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":47,"title":["Cathepsin K Knockout Alleviates Pressure Overload\u2013Induced Cardiac Hypertrophy"],"prefix":"10.1161","volume":"61","author":[{"given":"Yinan","family":"Hua","sequence":"first","affiliation":[{"name":"From the Division of Pharmaceutical Sciences &amp; Center for Cardiovascular Research and Alternative Medicine, University of Wyoming College of Health Sciences, Laramie, WY (Y.H., X.X., J.R., S.N.); Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA (G.-P.S.); and Department of Health and Exercise Science, Colorado State University, Fort Collins, CO (A.J.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihui","family":"Xu","sequence":"additional","affiliation":[{"name":"From the Division of Pharmaceutical Sciences &amp; Center for Cardiovascular Research and Alternative Medicine, University of Wyoming College of Health Sciences, Laramie, WY (Y.H., X.X., J.R., S.N.); Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA (G.-P.S.); and Department of Health and Exercise Science, Colorado State University, Fort Collins, CO (A.J.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Shi","sequence":"additional","affiliation":[{"name":"From the Division of Pharmaceutical Sciences &amp; Center for Cardiovascular Research and Alternative Medicine, University of Wyoming College of Health Sciences, Laramie, WY (Y.H., X.X., J.R., S.N.); Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA (G.-P.S.); and Department of Health and Exercise Science, Colorado State University, Fort Collins, CO (A.J.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Chicco","sequence":"additional","affiliation":[{"name":"From the Division of Pharmaceutical Sciences &amp; Center for Cardiovascular Research and Alternative Medicine, University of Wyoming College of Health Sciences, Laramie, WY (Y.H., X.X., J.R., S.N.); Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA (G.-P.S.); and Department of Health and Exercise Science, Colorado State University, Fort Collins, CO (A.J.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[{"name":"From the Division of Pharmaceutical Sciences &amp; Center for Cardiovascular Research and Alternative Medicine, University of Wyoming College of Health Sciences, Laramie, WY (Y.H., X.X., J.R., S.N.); Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA (G.-P.S.); and Department of Health and Exercise Science, Colorado State University, Fort Collins, CO (A.J.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreejayan","family":"Nair","sequence":"additional","affiliation":[{"name":"From the Division of Pharmaceutical Sciences &amp; Center for Cardiovascular Research and Alternative Medicine, University of Wyoming College of Health Sciences, Laramie, WY (Y.H., X.X., J.R., S.N.); Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA (G.-P.S.); and Department of Health and Exercise Science, Colorado State University, Fort Collins, CO (A.J.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1983"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31044"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000242332.19693.e4"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.04.010"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000242331.99369.2f"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.071126"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328341cedf"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.48.32347"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.108.172320"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0350"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000130641.08705.45"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.23.13453"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/hq0302.105287"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1596"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0229-0"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0350"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.11.011"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2006.04.005"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.01311"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2006.01.017"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.111.066712"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42918"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.47.120505.105359"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.23.6341"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1150110"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.111.00947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:57:30Z","timestamp":1715576250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.111.00947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.111.00947"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.111.00947","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"2012-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-03-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-03-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}